US Pharm. 2009;34:5(Oncology suppl):14.
National Cancer Institute (NCI) Director John E. Niederhuber, MD, announced the funding of more grants, the development of a platform for personalized cancer care, and an accelerated cancer genetics program at the American Association of Cancer Research 100th Annual Meeting in Denver. The 2009 fiscal year funding increases, which total nearly 3%, follow several years of flat or decreasing budgets.
Among the plans to bolster cancer research detailed by Niederhuber were the following: an increase in the NCI payline to fund a greater number of meritorious investigator-initiated projects; more grants to first-time investigators; help to universities for assisting and training new faculty investigators; development of a personalized cancer care platform; and a new network of Physical Sciences-Oncology Centers.
The various components of the breast cancer pathology examination and their impact on disease pathogenesis will be discussed.